366 related articles for article (PubMed ID: 20737186)
1. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
3. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
4. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.
Savage E; Wazir T; Drake M; Cuthbert R; Wright G
Rheumatology (Oxford); 2014 Jul; 53(7):1352-3. PubMed ID: 24609056
[No Abstract] [Full Text] [Related]
5. Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.
Ichikawa T; Shimojima Y; Otuki T; Ueno KI; Kishida D; Sekijima Y
Intern Med; 2019 Dec; 58(23):3473-3478. PubMed ID: 31391399
[TBL] [Abstract][Full Text] [Related]
6. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
[TBL] [Abstract][Full Text] [Related]
7. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Plate A; Vallelian F; Herfs G
Praxis (Bern 1994); 2016; 105(25):1503-1506. PubMed ID: 27976958
[No Abstract] [Full Text] [Related]
9. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
Kadavath S; Zapantis E; Zolty R; Efthimiou P
Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
[TBL] [Abstract][Full Text] [Related]
10. Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
Zhang G; Liu W; Zhang X; Liu L
Z Rheumatol; 2022 May; 81(4):335-338. PubMed ID: 34378080
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
12. Reintroduction of tocilizumab elicited macrophage activation syndrome in a patient with adult-onset Still's disease with a previous successful tocilizumab treatment.
Naniwa T; Uehara K; Yamabe T; Ohmura SI
Mod Rheumatol Case Rep; 2021 Jul; 5(2):360-364. PubMed ID: 32883165
[TBL] [Abstract][Full Text] [Related]
13. A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.
Nakahara H; Mima T; Yoshio-Hoshino N; Matsushita M; Hashimoto J; Nishimoto N
Mod Rheumatol; 2009; 19(1):69-72. PubMed ID: 18762861
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
[TBL] [Abstract][Full Text] [Related]
15. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
16. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
17. Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
Kishida D; Okuda Y; Onishi M; Takebayashi M; Matoba K; Jouyama K; Yamada A; Sawada N; Mokuda S; Takasugi K
Mod Rheumatol; 2011 Apr; 21(2):215-8. PubMed ID: 20931272
[TBL] [Abstract][Full Text] [Related]
18. [Adult onset Still's disease with small vessel vasculitis].
Hoff P; Hoyer BF; Schneider U; Kneitz C; Burmester GR; Buttgereit F
Z Rheumatol; 2015 Aug; 74(6):540-2. PubMed ID: 26231832
[TBL] [Abstract][Full Text] [Related]
19. Adult-onset Still's disease with neurological involvement: a single-centre report.
Zhao M; Wu D; Shen M
Rheumatology (Oxford); 2021 Sep; 60(9):4152-4157. PubMed ID: 33369675
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab.
Matsumoto K; Nagashima T; Takatori S; Kawahara Y; Yagi M; Iwamoto M; Okazaki H; Minota S
Clin Rheumatol; 2009 Apr; 28(4):485-7. PubMed ID: 19184270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]